HomeBCLI • NASDAQ
add
Brainstorm Cell Therapeutics Inc
Previous close
$1.18
Day range
$1.09 - $1.18
Year range
$0.72 - $6.45
Market cap
8.65M USD
Avg Volume
2.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.09M | 24.86% |
Net income | -2.86M | 15.79% |
Net profit margin | — | — |
Earnings per share | -0.45 | — |
EBITDA | -3.04M | -26.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | 111.04% |
Total assets | 3.57M | 6.66% |
Total liabilities | 11.03M | 23.94% |
Total equity | -7.46M | — |
Shares outstanding | 7.94M | — |
Price to book | -1.26 | — |
Return on assets | -285.86% | — |
Return on capital | 124.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.86M | 15.79% |
Cash from operations | -1.63M | 46.75% |
Cash from investing | — | — |
Cash from financing | 3.09M | 21.54% |
Net change in cash | 1.46M | 377.67% |
Free cash flow | -522.62K | 75.66% |
About
Founded
2000
Website
Employees
29
